-

Bruker Announces New Fraport AG Framework Contract for ETD Systems

Largest German airport FRA to modernize passenger security with up to 220 Bruker high-performance explosives trace detector (ETD) systems DE-tector™ flex

FRANKFURT, Germany--(BUSINESS WIRE)--Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex explosives and narcotics trace detectors to support their airport security measures. The installations are planned over a multi-year period from 2023 to 2027 to modernize the screening of passengers at Germany’s busiest airport FRA. The next-generation, high-performance Bruker DE-tector flex systems are intended to replace earlier-generation Bruker ETD systems at Frankfurt airport.

The Bruker DE-tector flex is a next-generation transportable explosives and narcotics trace detector that meets the requirements of two important security applications in airports, namely drugs (D) and explosives (E) detection. By wiping surfaces with multi-use, disposable swabs, and inserting them into the DE-tector flex, traces of most explosives and many illegal drug substances can be identified automatically within seconds. The new DE-tector flex system is certified by ECAC (European Civil Aviation Conference) as well as by national authorities, and it utilizes a non-radioactive ionization source.

“These next-generation systems will replace earlier explosive trace detectors at Frankfurt Airport and modernize the screening of passengers. The certification of the DE-tector flex system provides us with confidence that we are utilizing the most innovative and safe technology available. We look forward to continuing our partnership with Bruker to ensure the safety and security of our passengers and of the aviation industry," commented Sascha König, Head of Resource Management and Infrastructure Terminals, Fraport AG.

Dr. Andreas Kamlowski, President of the Bruker Optics Division, stated: “We are delighted that Fraport AG has again selected Bruker to provide innovative and reliable solutions to support the safety and security of the public and of the aviation industry. Bruker is fully committed to continue the long-term supplier partnership that started with the first installation of Bruker ETD detectors at FRA in 2015.”

About Bruker Corporation
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Contacts

Investor:
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

Media:
Michael Mueller
Marketing Manager
Bruker Optics GmbH & Co. KG
T: +49 7243 504 2652

Bruker Corporation

NASDAQ:BRKR

Release Versions
$Cashtags
Hashtags

Contacts

Investor:
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

Media:
Michael Mueller
Marketing Manager
Bruker Optics GmbH & Co. KG
T: +49 7243 504 2652

Social Media Profiles
More News From Bruker Corporation

Bruker Corporation to Present at Upcoming Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York City Wednesday, September 16, 2026, at 10:45 a.m. Eastern Time Bank of America Global Healthcare Conference in London, UK Tuesday, September 22, 2026, at 6:45 a....

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

HANAU, Germany--(BUSINESS WIRE)--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and e...

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

BOSTON--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary. Financial details were not disclosed. Atinary intends to integrate Chemspeed configurable laboratory automation platforms, Bruker analytical instruments and SciY sc...
Back to Newsroom